Name: Taltz® (ixekizumab) injection 80mg/mL: A COAST-to-COAST Treatment
Start: 2022-11-08T12:30:00-05:00
End: 2022-11-08T13:30:00-05:00

THE OFFICIAL NEWS SOURCE OF ACR CONVERGENCE 2022 • NOVEMBER 10-14

FEATURED

Choose an in-person or virtual experience for ACR Convergence 2022

Jul. 27, 2022

Registration is open for this year’s premier rheumatology experience, taking place November 10-14 in Philadelphia. Don’t miss special pricing for early registration, available through August 30, for in-person and virtual participation. READ MORE

SESSION PREVIEWS

Planning Committee Chair Dr. Sharon Kolasinski previews ACR Convergence 2022

Jul. 27, 2022

ACR Convergence 2022 will offer the most comprehensive presentation of basic science, clinical research, and advances in clinical care in rheumatology, with the choice of in-person or virtual registration. Annual Meeting Planning Committee Chair Sharon L. Kolasinski, MD, FACR, provides a first look at what attendees can expect from the meeting “where rheumatology meets.” READ MORE
New findings inform new approaches to Sjögren’s

Feb. 4, 2022

At ACR Convergence 2021, a panel of experts — A. Darise Farris, PhD, Blake M. Warner, DDS, PhD, MPH, and Xavier Mariette, MD, PhD — explored the dynamics of the treatment of Sjögren’s syndrome, including epigenetic links between immune and salivary gland dysfunction and targeted therapy. READ MORE
Age is a key factor in effective immune response

Feb. 4, 2022

Cornelia M. Weyand, MD, PhD, explored the mechanisms and sequelae of aging immune systems during ACR Convergence 2021. For even the healthiest humans, the age-related risk of cancer, cardiovascular disease, infectious disease, and neurodegenerative disease comes back to one factor: older immune systems are less flexible, less responsive, and less effective. READ MORE

Some chronic pain can be managed without drugs

Feb. 4, 2022

Rinie Geenen, PhD, discussed pain management regimens in rheumatic and musculoskeletal diseases, Christine Stamatos, DNP, ANP-C, discussed targeted pharmacologic and nonpharmacologic therapies for chronic pain, and Afton Hassett, PysD, outlined behavioral interventions as pain management. READ MORE
Post-COVID-19 syndromes can affect several systems

Jan. 21, 2022

In an ACR Convergence symposium, Anthony L. Komaroff, MD, discussed neurological syndromes associated with long COVID, Matthew Ehrlich, MD, discussed the mental health impact of the pandemic, and George A. Alba, MD, discussed the pulmonary sequelae of COVID-19. READ MORE
Expanded provider reach, patient time savings boost popularity of telemedicine

Jan. 21, 2022

Nearly 90% of all physicians had used telehealth by the end of 2020, about half of them for the first time. Jesse D. Overbay, JD, explained this pandemic-induced shift in medicine and its lasting impact on clinical practice. READ MORE

Kaitlin Quinn, MD: Standardizing clinical trial recruitment in Takayasu arteritis

Nov. 8, 2021

Kaitlin Quinn, MD, will present the poster “Using 18F-fluorodeoxyglucose Positron Emission Tomography to Standardize Clinical Trial Recruitment in Takayasu’s Arteritis” during Tuesday morninng’s Poster Session D. READ MORE

Simón Ángel Sánchez-Fernández, PhD: SARS-CoV-2 infection in rheumatic disease patients receiving biological therapies

Nov. 8, 2021

Simón Ángel Sánchez-Fernández, PhD, will present the poster “Evaluation of the Possible Different Evolution of SARS-CoV-2 Infection with Tumor Necrosis Factor Inhibitors or with Rituximab in Rheumatic Patients” during Tuesday morninng’s Poster Session D. READ MORE
Ingrid Jyssum, MD: COVID-19 vaccine response in patients with inflammatory arthritis and IBD

Nov. 8, 2021

Ingrid Jyssum, MD, will present the poster “Immune Responses to COVID-19 Vaccines in Patients Using Immunosuppressive Medication for Inflammatory Arthritis – An Observational Study of 1500 Patients” during Tuesday morninng’s Poster Session D. READ MORE

MORE POSTER COVERAGE

Planning Committee Chair Dr. Sharon Kolasinski previews ACR Convergence 2022

Jul. 27, 2022

ACR Convergence 2022 will offer the most comprehensive presentation of basic science, clinical research, and advances in clinical care in rheumatology, with the choice of in-person or virtual registration. Annual Meeting Planning Committee Chair Sharon L. Kolasinski, MD, FACR, provides a first look at what attendees can expect from the meeting “where rheumatology meets.” READ MORE